Evidence map›Paper›PMID 41751514›Full record

ArticleGenes2026

Phenotypic and Whole-Genome Sequencing-Based Profiling of Antimicrobial Resistance and Virulence in

Marija Cavka, Marija Kvesic Ivankovic, Ana Maravic, Mia Dzelalija, Jelena Marinovic, Ivana Goic-Barisic, Marija Tonkic, Anita Novak

Abstract read
In one paragraph

Article in Genes, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Marija CavkaDepartment of Anesthesiology and Intensive Care, University Hospital of Split, Spinciceva 1, 21 000 Split, Croatia.
Marija Kvesic IvankovicInstitute of Oceanography and Fisheries, Setaliste Ivana Mestrovica 63, 21 000 Split, Croatia.ORCID 0000-0001-7009-5947
Ana MaravicDepartment of Biology, Faculty of Science, University of Split, Rudera Boskovica 33, 21 000 Split, Croatia.
Mia DzelalijaDepartment of Biology, Faculty of Science, University of Split, Rudera Boskovica 33, 21 000 Split, Croatia.ORCID 0000-0002-7284-9519
Jelena MarinovicDepartment of Clinical Microbiology, University Hospital of Split, Spinciceva 1, 21 000 Split, Croatia.
Ivana Goic-BarisicDepartment of Clinical Microbiology, University Hospital of Split, Spinciceva 1, 21 000 Split, Croatia.ORCID 0000-0002-1030-6092
Marija TonkicDepartment of Clinical Microbiology, University Hospital of Split, Spinciceva 1, 21 000 Split, Croatia.
Anita NovakDepartment of Clinical Microbiology, University Hospital of Split, Spinciceva 1, 21 000 Split, Croatia.ORCID 0000-0002-6330-4058

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND/

objectives

methodsThe study included

resultsA high rate of resistance was detected to ceftazidime (23.4%), imipenem (39.6%), and meropenem (43.8%). WGS confirmed the presence of multiple AMR genes, including the

conclusionsDue to the emergence of high-risk clones with broad AMR and strong virulence potential, ineffectiveness of standard empirical therapy may be anticipated, highlighting the urgent need for new therapeutic approaches (including those targeting major virulence factors).

Indexed as

BronchitisDrug Resistance, Multiple, BacterialPneumonia, Ventilator-AssociatedPseudomonas aeruginosaPseudomonas InfectionsTracheitisAnti-Bacterial AgentsCroatiaGenome, BacterialHumansIntensive Care UnitsMicrobial Sensitivity TestsMultilocus Sequence TypingPhenotypeVirulenceVirulence FactorsAnti-Bacterial AgentsVirulence Factorsgenetic contexthospital-acquired pneumoniaintensive care unitmultidrug-resistancePseudomonas aeruginosaVIM-2whole-genome sequencing

Identifiers

PMID41751514
PMCPMC12940210

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.